Coagulation testing is used to evaluate blood clotting and assess bleeding disorders and anticoagulant therapy.The market for coagulation testing is driven by the rising incidence of age-related diseases and advancements in technology.Expansion of healthcare facilities and favorable regulatory frameworks also contribute to market growth.Key players in the coagulation testing market include Sysmax Corporation, Thermo Fisher Scientific Inc., and Abbott Laboratories.